Hecla Mining Co. (NYSE:HL) will release its 2010 fourth quarter results after market close on Wednesday, February 16, 2011. A conference call and webcast will be held Thursday, February 17, at 10:00 a.m. Eastern Time to discuss these results. You may join the conference call by dialing toll-free 1-800-299-8538 or 1-617-786-2902 internationally. The participant passcode is HECLA. Hecla’s live and archived webcast can be accessed at www.hecla-mining.com.
Hecla Mining Company engages in the discovery, acquisition, development, production, and marketing of silver, gold, lead, and zinc. It owns a 100% interest in the Lucky Friday unit located in northern Idaho; and a 100% interest in the Greens Creek unit located on Admiralty Island, near Juneau, Alaska.
Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. The acquisition of Rozetta-Cell is expected to be completed in February 2011, according to Company management.
Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
“We are very excited to be acquiring Rozetta-Cell Life Sciences,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “Rozetta-Cell brings us a tremendous amount of complementary adult stem cell therapy technology, know-how and experience. With the addition of Rozetta-Cell, Power3 will significantly strengthen its IP portfolio in a major growth market by merging regenerative medicine with the technologies that we are using to identify disease-specific protein biomarkers and develop them into screening and diagnostic tests to address unmet medical needs.”
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
NATIONAL HEALTH PARTNERS, INC. (OTC:NHPR) is a leading national healthcare savings organization that provides unique discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.”
CARExpress “Wrap-around” Program. Our CARExpress membership programs can be combined with various types of insurance products that enable clients to offer a fully integrated healthcare package. The use of insurance products in conjunction with our CARExpress membership programs can provide an affordable solution to individuals and groups who previously could not afford fully inclusive medical plans, and can provide greater assurance of payment to the healthcare providers. These products can be bundled, priced and marketed utilizing relationship marketing strategies or direct marketing to target the profiled needs of the clients’ particular member base.
Catastrophic Health Insurance. This type of insurance usually takes the form of a high deductible major medical policy in which the insurance company pays nothing until expenditures reach a threshold that is typically between $2,500 and $20,000.
Health Savings Accounts (HSAs). Health Savings Accounts (HSAs) were created by Public Law 108-173, the “Medicare Prescription Drug, Improvement and Modernization Act of 2003,” signed into law by President Bush on December 8, 2003. Health Savings Accounts change the way millions meet their health care needs because they help individuals save for qualified medical and retiree health expenses on a tax-advantaged basis.
NATIONAL HEALTH PARTNERS CARExpress membership programs can be designed as a supplement to HSA programs. Consumers can use our CARExpress programs to reduce their out-of-pocket costs when they use their HSA funds to pay qualified medical expenses.
Global Geophysical Services, Inc. (NYSE:GGS) announced that Richard Degner, President and CEO, and Mathew Verghese, Senior Vice President and CFO will present at the Credit Suisse Energy Summit in Vail, Colorado on Wednesday, February 9, 2011 at 11:25 a.m. EST.
Global Geophysical Services, Inc., doing business as GGS Seismic, Inc., provides high density three dimensional land and transition zone seismic data acquisition solutions in the United States and internationally.
The E. W. Scripps Company (NYSE:SSP) will report fourth quarter 2010 operating results before New York Stock Exchange trading begins on Thursday, Feb. 24. A telephone conference call with members of the company's senior management team will follow at 9 a.m. Eastern. Scripps will offer a live webcast of the conference call. To access the webcast, visit www.scripps.com.
The E. W. Scripps Company, together with its subsidiaries, operates as a diverse media company with interests in newspaper publishing, television stations, and licensing and syndication.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and anticipates receiving 3,000,000 shares of free trading shares from a third party for six months of advertisement services for National Health Partners Inc. (OTC:NHPR).